Tauriga Sciences, Inc. announced the appointment of Hingge Hsu, to its Board of Directors. Dr. Hingge Hsu was recently a Partner at Fidelity Biosciences and was on the core healthcare investment team for Fidelity Growth Partners Asia. He was previously a Managing Director at Lehman Brothers in their Private Equity Group.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
2022 | Tauriga Sciences Inc. Receives its 10,000th E-Commerce Order | CI |
2022 | Tauriga Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 | CI |
1st Jan change | Capi. | |
---|---|---|
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- TAUG Stock
- News Tauriga Sciences, Inc.
- Tauriga Sciences, Inc. Appoints Hingge Hsu to its Board of Directors